These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15552778)

  • 21. Application of serum SELDI proteomic patterns in diagnosis of lung cancer.
    Yang SY; Xiao XY; Zhang WG; Zhang LJ; Zhang W; Zhou B; Chen G; He DC
    BMC Cancer; 2005 Jul; 5():83. PubMed ID: 16029516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement factor H is elevated in bronchoalveolar lavage fluid and sputum from patients with lung cancer.
    Pio R; Garcia J; Corrales L; Ajona D; Fleischhacker M; Pajares MJ; Cardenal F; Seijo L; Zulueta JJ; Nadal E; Witt C; Lozano MD; Schmidt B; Montuenga LM
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2665-72. PubMed ID: 20802023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for lung cancer: New horizons?
    Rossi A; Maione P; Colantuoni G; Gaizo FD; Guerriero C; Nicolella D; Ferrara C; Gridelli C
    Crit Rev Oncol Hematol; 2005 Dec; 56(3):311-20. PubMed ID: 15978829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular alterations in spontaneous sputum of cancer-free heavy smokers: results from a large screening program.
    Baryshnikova E; Destro A; Infante MV; Cavuto S; Cariboni U; Alloisio M; Ceresoli GL; Lutman R; Brambilla G; Chiesa G; Ravasi G; Roncalli M
    Clin Cancer Res; 2008 Mar; 14(6):1913-9. PubMed ID: 18347195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteomic approaches in lung cancer biomarker development.
    Cho JY; Sung HJ
    Expert Rev Proteomics; 2009 Feb; 6(1):27-42. PubMed ID: 19210125
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New approaches for biomarker discovery in lung cancer.
    Valle RP; Chavany C; Zhukov TA; Jendoubi M
    Expert Rev Mol Diagn; 2003 Jan; 3(1):55-67. PubMed ID: 12528364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early detection of lung cancer.
    Szabo E; Birrer MJ; Mulshine JL
    Semin Oncol; 1993 Aug; 20(4):374-82. PubMed ID: 8342067
    [No Abstract]   [Full Text] [Related]  

  • 28. Hypermethylation of ASC/TMS1 is a sputum marker for late-stage lung cancer.
    Machida EO; Brock MV; Hooker CM; Nakayama J; Ishida A; Amano J; Picchi MA; Belinsky SA; Herman JG; Taniguchi S; Baylin SB
    Cancer Res; 2006 Jun; 66(12):6210-8. PubMed ID: 16778195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reducing the risk of overdiagnosis in lung cancer: a support from molecular biology.
    Barba M; Felsani A; Rinaldi M; Giunta S; Malorni W; Paggi MG
    J Cell Physiol; 2011 Sep; 226(9):2213-4. PubMed ID: 21660943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction.
    Sueoka E; Sueoka N; Iwanaga K; Sato A; Suga K; Hayashi S; Nagasawa K; Nakachi K
    Lung Cancer; 2005 Apr; 48(1):77-83. PubMed ID: 15777973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Future of early detection of lung cancer: the role of mouse models.
    Shaw AT; Kirsch DG; Jacks T
    Clin Cancer Res; 2005 Jul; 11(13 Pt 2):4999s-5003s. PubMed ID: 16000603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer.
    Spira A; Beane JE; Shah V; Steiling K; Liu G; Schembri F; Gilman S; Dumas YM; Calner P; Sebastiani P; Sridhar S; Beamis J; Lamb C; Anderson T; Gerry N; Keane J; Lenburg ME; Brody JS
    Nat Med; 2007 Mar; 13(3):361-6. PubMed ID: 17334370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?
    Bremnes RM; Sirera R; Camps C
    Lung Cancer; 2005 Jul; 49(1):1-12. PubMed ID: 15949585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lung cancer: rational strategies for early detection and intervention.
    Mulshine JL; Treston AM; Scott FM; Avis I; Boland C; Phelps R; Kasprzyk PG; Nakanishi Y; Cuttitta F
    Oncology (Williston Park); 1991 May; 5(5):25-32; discussion 32-3, 37. PubMed ID: 1832003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging molecular biomarkers for early detection of lung cancer in patients at high risk.
    Price N
    Clin Lung Cancer; 2004 Nov; 6(3):145-8. PubMed ID: 15555214
    [No Abstract]   [Full Text] [Related]  

  • 36. Plasma proteomic profiling: search for lung cancer diagnostic and early detection markers.
    Ali IU; Xiao Z; Malone W; Smith M; Conrads TP; Veenstra TD; Greenwald P; Luke BT; McLarty JW
    Oncol Rep; 2006 May; 15(5):1367-72. PubMed ID: 16596212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoter methylation of genes in bronchial lavages: a marker for early diagnosis of primary and relapsing non-small cell lung cancer?
    de Fraipont F; Moro-Sibilot D; Michelland S; Brambilla E; Brambilla C; Favrot MC
    Lung Cancer; 2005 Nov; 50(2):199-209. PubMed ID: 16043258
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data.
    Kim B; Lee HJ; Choi HY; Shin Y; Nam S; Seo G; Son DS; Jo J; Kim J; Lee J; Kim J; Kim K; Lee S
    Cancer Res; 2007 Aug; 67(15):7431-8. PubMed ID: 17671213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Non-invasive molecular detection of bladder cancer].
    Hatachmi S
    Harefuah; 2009 Jan; 148(1):66-9, 86. PubMed ID: 19320394
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis.
    Dacic S
    Expert Rev Mol Diagn; 2007 Jan; 7(1):77-86. PubMed ID: 17187486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.